C
CHRS
Coherus
1.660
+0.020+1.22%After Hours: 1.720 +0.060 +3.61%19:38 05/27 EDT
OPEN/PREV CLOSE1.640/1.640
TODAY RANGE1.640-1.735
VOL1.20M
MARKET CAP256.05M
52 WEEK RANGE0.7100-2.616
AVG VOL (3M)1.30M
% TURNOVER0.78%
TURNOVER--
P/E (TTM)0.9965
% RANGE5.79%
EPS(TTM)1.666
P/E(FORWARD)-1.5091
P/B3.256
BVPS0.5098
DIVIDEND--
P/S4.769
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP203.53M
SHARES OUTSTANDING154.25M
NEXT EARNINGS08/05-08/10
FREE FLOAT122.61M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·05/20 01:12
Coherus Biosciences Signals Momentum in Earnings Call
Seeking Alpha·05/13 10:00
Coherus Oncology: Setting Up For Important Readouts In Mid-2026
TipRanks·05/13 00:12
Coherus Biosciences Signals Confident Oncology Earnings Outlook
TipRanks·05/12 12:06
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks·05/12 12:06
Oppenheimer Sticks to Their Buy Rating for Coherus Biosciences (CHRS)
TipRanks·05/11 23:20
Coherus Oncology reports Q1 EPS (28c), consensus (26c)
Reuters·05/11 20:20
Coherus Oncology Q1 sales rise
Seeking Alpha·05/11 20:16
Coherus BioSciences Non-GAAP EPS of -$0.25 beats by $0.02, revenue of $12.31M misses by $2.03M
Dow Jones·05/11 20:05
*Coherus Oncology 1Q Loss $38.3M >CHRS
Same Industry
Name/Symbol
Change%
Price